Reviva Pharmaceuticals Holdings Inc. Strategic Asset Allocation Index
Reviva Pharmaceuticals Holdings Inc. strategic asset allocation index. Reviva Pharmaceuticals Holdings Inc. (RVPH) has a Strategic Asset Allocation Index of 0.0% as of September 2020. Strategic assets (PP&E of $107.00 plus long-term investments of $-) total $107.00, measured against net assets of $30.10 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See RVPH equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Reviva Pharmaceuticals Holdings Inc. (2018–2018)
Strategic asset allocation index of Reviva Pharmaceuticals Holdings Inc. from 2018 to 2018. This chart shows how Reviva Pharmaceuticals Holdings Inc.'s Strategic Asset Allocation Index has evolved across 1 annual periods from 2018 to 2018. As of September 2020, the index stands at 0.0%, representing strategic assets of $107.00 against net assets of $30.10 Million USD. Check Reviva Pharmaceuticals Holdings Inc. (RVPH) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Reviva Pharmaceuticals Holdings Inc. Strategic Asset Allocation Index by Year (2018–2018)
Reviva Pharmaceuticals Holdings Inc. strategic asset allocation index by year from 2018 to 2018. The table below presents the year-by-year Strategic Asset Allocation Index for Reviva Pharmaceuticals Holdings Inc. from 2018 to 2018, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see RVPH market cap.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2018 | 0.0% | $1.24K | $1.24K | $- | $59.16 Million | — |